# Zibotentan Better Renal Scleroderma Outcome Study

> **NCT02047708** · PHASE2 · COMPLETED · sponsor: **University College, London** · enrollment: 27 (actual)

## Conditions studied

- Scleroderma
- Scleroderma Renal Crisis
- Chronic Kidney Disease

## Interventions

- **DRUG:** Zibotentan

## Key facts

- **NCT ID:** NCT02047708
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047708, "Zibotentan Better Renal Scleroderma Outcome Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02047708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*